Drug Report History #141977

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v2-FR
Language (Changed) Updated to: English Was: French
Date Updated (Changed) Updated to: 2021-09-08 Was: 2021-07-07
Drug Identification Number 02455935 02455935
Brand name INJECTABLE NALOXONE HYDROCHLORIDE INJECTABLE NALOXONE HYDROCHLORIDE
Common or Proper name Naloxone Hydrochloride Injection Naloxone Hydrochloride Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1mL vial / fiole 10 x 1mL vial / fiole
Additional packaging sizes
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date (Changed) Updated to: Was: 2021-07-23
Actual start date (Changed) Updated to: 2021-07-23 Was:
Estimated end date (Changed) Updated to: 2021-10-08 Was: 2021-07-31
Actual end date (Changed) Updated to: 2021-09-07 Was:
Shortage status (Changed) Updated to: Resolved Was: Anticipated shortage
Tier 3 Status No No
Company comments (Changed) Updated to: High Demand on Market. On and Off Backorder. Was:
Health Canada comments